What can you expect while undergoing rituximab treatment for indolent B-cell lymphoma?
Rituximab is a targeted therapy that works by attaching to a protein called CD20 found on B cells. Unlike chemotherapy, targeted therapies like rituximab are designed to recognize specific proteins on cancer cells, which means they Show Full Answer
What can you expect while undergoing rituximab treatment for indolent B-cell lymphoma?
Rituximab is a targeted therapy that works by attaching to a protein called CD20 found on B cells. Unlike chemotherapy, targeted therapies like rituximab are designed to recognize specific proteins on cancer cells, which means they typically don't affect normal cells as much as traditional chemotherapy does.
Since you have indolent (slow-growing) lymphoma, your treatment approach may be more gradual. With indolent conditions, doctors sometimes recommend a "watch and wait" approach initially, starting treatment only when symptoms develop or the condition progresses.
Common side effects during rituximab treatment may include:
- Gastrointestinal distress
- Headache
- Fever
- Low white blood cell counts (which can increase infection risk)
Infusion reactions can occur and may cause:
- Headache
- Dizziness
- Fever and chills
- Nausea
- Shortness of breath
These reactions typically happen during the drug infusion itself. Your medical team will monitor you closely during treatments.
Taking care of yourself during treatment is important. Getting enough rest, staying hydrated, and eating a healthy diet can help you manage side effects better. Always report any concerning symptoms to your healthcare team right away.
January 16
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
